Bifidobacterium animalis/lactobacillus rhamnosus Disease Interactions

There is 1 disease interaction with bifidobacterium animalis / lactobacillus rhamnosus.

Moderate

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Immunodeficiency, Immunodeficiency

Probiotics, especially those containing lactobacillus, should be used with caution in immunosuppressed patients.

References (3)

"Product Information. Culturelle DS (lactobacillus rhamnosus GG)." ConAgra Functional Foods
Salminen MK, Tynkkynen S, Rautelin H, et al. (2002) "Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland." Clin Infect Dis, 35, p. 1155-60
Land MH, Rouster-Stevens K, Woods CR, Cannon ML, Cnota J, Shetty AK (2005) "Lactobacillus sepsis associated with probiotic therapy." Pediatrics, 115, p. 178-81

There are 351 drug interactions with bifidobacterium animalis / lactobacillus rhamnosus.

QR code containing a link to this page

More about bifidobacterium animalis / lactobacillus rhamnosus

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major	Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate	Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor	Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown	No interaction information available.

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Drug Status

Availability Over the counter OTC

CSA Schedule* Not a controlled drug N/A

User Reviews & Ratings